Institutul Național de Boli Infecțioase „Prof. Dr. Matei Balș” este un spital din București. Până în 1999 a purtat numele Spitalul Clinic de Boli Infecțioase Colentina. Din martie 1999, prin ordin al Ministerului Sănătății, Spitalul Clinic de Boli Infecțioase Colentina a devenit Institutul de Boli Infecțioase Prof.

During the past decade, Institutul National de Boli Infectioase Prof.Dr.Matei Bals conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institutul National de Boli Infectioase Prof.Dr.Matei Bals" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Biolex Therapeutics, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institutul National de Boli Infectioase Prof.Dr.Matei Bals" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institutul National de Boli Infectioase Prof.Dr.Matei Bals" are "Chronic Hepatitis B" (3 trials), "Hepatitis B, Chronic" (3 trials), "HBV" (2 trials), "Hepatitis C, Chronic" (2 trials) and "COVID-19 Infection" (1 trials). Many other conditions were trialed in "Institutul National de Boli Infectioase Prof.Dr.Matei Bals" in a lesser frequency.

Most popular intervention types in "Institutul National de Boli Infectioase Prof.Dr.Matei Bals" are "Drug" (16 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "TAF" (3 trials), "TDF" (3 trials), "ATM-AVI" (2 trials), "Placebo" (2 trials) and "Remdesivir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institutul National de Boli Infectioase Prof.Dr.Matei Bals" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Institutul National de Boli Infectioase Prof.Dr.Matei Bals". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Institutul National de Boli Infectioase Prof.Dr.Matei Bals, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Institutul National de Boli Infectioase Prof.Dr.Matei Bals, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".